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ABSTRACT OF THESIS 
 
 
 
 
 
THE EFFECT OF NICOTINE CO-ADMINISTRATION ON ALCOHOL-INDUCED 
REACTIVE HIPPOCAMPAL CELL PROLIFERATION DURING ABSTINENCE IN AN 
ADOLESCENT MODEL OF AN ALCOHOL USE DISORDER 
 
 A significant consequence of alcohol use disorders (AUDs) is hippocampal 
neurodegeneration. The hippocampus is responsible for learning and memory, and 
neurodegeneration in this brain region has been shown to result in cognitive deficits. 
Interestingly, some alcoholics demonstrate improvements in hippocampus-dependent 
functions, potentially due the phenomenon termed adult neurogenesis. Adult 
neurogenesis, the process by which neural stem cells (NSCs) proliferate, differentiate 
into neurons, migrate into the granule cell layer, and survive, occurs in two brain regions; 
however, this study examines only neurogenesis occurring in the subgranular zone of 
the hippocampal dentate gyrus. Four-day binge ethanol exposure in an animal model 
causes a decrease in neurogenesis during intoxication; however, there is a reactive 
increase in cell proliferation on day seven of abstinence. The purpose of this study was 
to determine the timing of increased cell proliferation. Furthermore, most alcoholics also 
smoke tobacco, and nicotine, the addictive component of tobacco, has also been shown 
to affect hippocampal neurogenesis. As many people initiate alcohol and tobacco use 
during adolescence, the second experiment herein examined the effect of nicotine co-
administration on alcohol-induced reactive hippocampal cell proliferation. 
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Chapter One: Introduction 
Alcohol Use Disorder (AUD) Definitions and Epidemiology 
The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) outlines the 
requirements for the diagnosis of an alcohol use disorder (AUD). In order to be 
diagnosed with an AUD, a person must meet two out of eleven criteria within the past 12 
month period. These criteria include: (1) tolerance to the effects of alcohol, (2) 
withdrawal during abstinence, (3) persistent use despite knowledge of recurrent 
physical/psychological or (4) interpersonal problems resulting from alcohol use, (5) 
repeated use in physically dangerous situations, (6) sacrifice of social, occupational, or 
recreational activities because of alcohol, (7) use even when alcohol causes repeated 
failures at home, school, or work, (8) craving, (9) persistent desire for or inability to 
reduce the amount of alcohol consumed, (10) significant amount of time spent obtaining, 
using, or recovering from alcohol, (11) a greater amount of alcohol consumed or 
consumed for longer than intended (American Psychiatric Association, 2013). The 
severity of the AUD is then determined according to the number of criteria met: two to 
three symptoms indicate a mild AUD, four to five symptoms indicate a moderate AUD, 
and 6 or more symptoms indicate a severe AUD. Epidemiologic data show that 
according to DSM-5 criteria, the 12-month prevalence of an AUD from 2012-2013 was 
13.9% and the lifetime prevalence of an AUD was 29.1% (Grant et al., 2015). This is a 
5% increase from the 12-month prevalence in 2001-2002 of 8.5% that was based on 
DSM-IV criteria (Grant et al., 2004) and likely reflects changes to inclusion criteria for an 
AUD diagnosis in the DSM-5. Not only does excessive drinking affect the individuals with 
AUDs, but it also costs the U.S. economy approximately $223.5 billion each year 
(Bouchery et al., 2011). Because of the combined harm to the individual and the harms 
to society, the WHO and others have ranked alcohol as the greatest harm to society of 
all of the drugs of abuse (Nutt et al., 2010). 
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Binge drinking is a risky pattern of alcohol consumption in which a person rapidly 
attains a high blood ethanol concentration (BEC). The National Institute on Alcohol 
Abuse and Alcoholism defines binge drinking as drinking that results in a BEC of at least 
0.08 mg/dL (2016). This BEC may be attained when men consume four drinks (or five 
drinks for women) within approximately two hours. In survey results from 2014, nearly 
23% of adults over the age of 25 years old reported that they had engaged in binge 
alcohol drinking within the past month (Johnston et al., 2015). Furthermore, binge 
drinking is also thought to increase the risk of brain damage (Hunt, 1993). These 
definitions are important to keep in mind while studying any aspect of alcohol use 
disorders. 
 
Adolescent Alcohol Consumption 
Adolescence is defined by the WHO as the period between the ages of 10 and 
19 years old (World Health Organization). Adolescents most commonly begin consuming 
alcohol between the ages of 12 and 14 years (Faden, 2006). Furthermore, 25% of 10th 
grade students reported in a 2014 survey that they had been drunk at some point, and 
10.8% of 16 year olds reported that they had engaged in binge drinking (Miech et al., 
2015). Although adolescents generally consume alcohol less frequently than adults (~6 
days per month for 12-20 year olds versus ~9 days per month for adults over 25 years 
old), they tend to consume a greater number of drinks than adults when they do drink 
(~5 drinks per occasion for 12-20 year old versus ~3 drinks per occasion for adults over 
25 years old (Johnston et al., 2007)). One possible explanation for the fact that 
adolescents tend to consume more alcohol at a time than adults is that they have been 
shown to be less sensitive to both the sedating effects of alcohol (Little et al., 1996, 
Silveri and Spear, 1998, White et al., 2002) and “hangover” effects (Varlinskaya and 
Spear, 2004), but are more sensitive to the rewarding properties of alcohol and social 
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facilitation (Varlinskaya and Spear, 2010). Not only does ethanol have an acute effect on 
adolescent drinkers, but it may also continue to affect them during adulthood. The 
younger a person is when they start consuming alcohol, the higher their risk for 
developing an AUD at some point during their life. For example, adolescents who start 
drinking when they are 13 years old or younger with a family history of alcoholism have a 
57% chance of developing an AUD (Grant, 1998). Even these adolescents with no family 
history of alcoholism have a 26% chance of developing an AUD (Grant, 1998). This high 
risk of alcohol dependence is in stark contrast to the risk for those who do not initiate 
alcohol consumption until adulthood; adults who are at least 21 years old with a family 
history of an AUD have a 16% chance and those without a family history have only a 
6.5% chance of developing an AUD (Grant, 1998). This epidemiological data 
demonstrates the importance of studying adolescent alcohol use. 
 
Ethanol Pharmacology 
Ethanol, commonly referred to as alcohol and used interchangeably herein, is a 
polar, water and lipid-soluble compound with the molecular formula CH3CH2OH. Once 
absorbed through the gastrointestinal tract, it is metabolized in the liver by alcohol 
dehydrogenase (ADH) to acetaldehyde and then by acetaldehyde dehydrogenase 
(ALDH) to acetic acid and water. A smaller portion of ethanol is also oxidatively 
metabolized via the cytochrome P450 liver enzyme (CYP) 2E1 to reactive oxygen 
species. 
Alcohol is a promiscuous drug that has many different sites and mechanisms of 
action. It enhances the activity of 5-HT3, GABAA, glycine, and nicotinic acetylcholine 
receptors (nAChRs) and inhibits the activity of NMDA receptors (Vengeliene et al., 
2008). Furthermore, it inhibits dihydropyridine-sensitive L-type Ca2+ channels, opens G-
protein-activated inwardly rectifying K+ channels, and modulates dopaminergic, opioid, 
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peptide hormone, and endocannabinoid systems (Vengeliene et al., 2008). Alcohol’s 
interactions with these various receptors and ion channels is dependent on the 
conformation of receptor and channel subunits and the concentration of alcohol present 
(Vengeliene et al., 2008); for example, ethanol inhibits α7 nAChRs but potentiates α4β2 
nAChRs (Cardoso et al., 1999).  
 
Nicotine Pharmacology 
 Tobacco is responsible for the deaths of 6 million people each year and roughly 
half of users eventually die from it (World Health Organization, 2015). Nicotine, which is 
widely considered to be the addictive component of tobacco, binds nicotinic 
acetylcholine receptors (nAChRs). These receptors are ligand-gated ion channels that 
bind endogenous acetylcholine. nAChRs have a pentameric structure made up of alpha, 
beta, gamma, delta, and epsilon subunits; however, the nAChRs in the central nervous 
system (CNS) consist of only alpha and beta subunits. The most common subtypes 
found within the brain are α4β2 and α7 and both of the subtypes exist in the 
hippocampus. When nAChRs are bound by an agonist, the channel opens and cations 
including sodium and calcium enter resulting in membrane depolarization. Voltage-
dependent calcium channels then become activated, which increases intracellular 
calcium and activates cell signaling pathways. Nicotine binding to nAChRs on 
presynaptic neurons causes the release of various neurotransmitters into the synaptic 
cleft.  
 Agonism of the α4β2 subtype of nAChRs in the ventral tegmental area (VTA) by 
nicotine is thought to be the source of its addictive properties (Picciotto et al., 1998, 
Mansvelder and McGehee, 2002). Nicotine is a unique substrate in that when it binds to 
its receptor, it causes receptor upregulation. nAChRs also eventually become 
desensitized in the presence of nicotine and, essentially, are rendered inactive. For 
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example, α4β2 nAChRs become quickly desensitized in the presence of nicotine 
following a brief period of activation (Dani and Harris, 2005). Alpha7 nAChRs, however, 
have a lower affinity for nicotine and generally require higher nicotine concentrations to 
become desensitized by it (Fenster et al., 1997). Alpha7 receptors, which have a higher 
permeability to calcium than other nAChRs, are present on presynaptic glutamatergic 
neurons and excite DA neurons through activation of glutamatergic afferents 
(Pidoplichko et al., 1997, Albuquerque et al., 2009). 
 In general, nicotine is thought to have beneficial effects on cognitive function via 
its effects on the cholinergic system. Animal models have shown that both acute and 
chronic nicotine administration improves learning and memory as measured by 
performance in the Morris water maze, radial-arm maze, Lashley III maze, one-way 
active avoidance tasks, and object recognition tasks (reviewed in (Levin et al., 2006)). 
Furthermore, it has also been shown to increase attention in rats when measured by the 
visual signal detection test and five-choice serial reaction time test (Levin et al., 2006). 
Nicotine is thought to enhance cognitive function both through direct action on nAChRs 
and by causing the release of other neurotransmitters including glutamate, serotonin, 
dopamine, and GABA (Levin et al., 2006). Intriguingly, nicotine has been shown to 
reduce hippocampal neurogenesis, which will be reviewed in later sections of this 
document.    
 
Alcohol and Nicotine Interactions 
 As 50-92% of people with an AUD also smoke, it is highly important to study 
these two drugs together in order to model the actual human condition (Miller and Gold, 
1998, Falk et al., 2006, De Leon et al., 2007, Van Skike et al., 2016). Alcoholics are 
more likely to smoke than nonalcoholics and have more difficulty quitting smoking 
(DiFranza and Guerrera, 1990). Furthermore, nicotine and ethanol have been shown to 
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interact with each other in humans and animal models. In human subjects, ethanol 
potentiated the rewarding effects of nicotine, according to rates of satisfaction resulting 
from smoking a cigarette after consuming a dose of alcohol that resulted in a BEC of 
0.03 g/dL (Rose et al., 2002). Nicotine has also been shown to promote compulsive 
alcohol drinking in nicotine-dependent rats (Leao et al., 2015), and humans given 
cigarettes with low nicotine content consumed less alcohol than those who smoked 
regular cigarettes (Dermody et al., 2016). Nicotine may also alleviate some of alcohol’s 
withdrawal symptoms by decreasing the upregulation of GABAA that occurs during 
abstinence from alcohol (Staley et al., 2005). Moreover, as previously discussed, alcohol 
interacts directly with nAChRs. In fact, mecamylamine, a nicotinic receptor antagonist, 
has been shown to reduce ethanol-induced DA release into the nucleus accumbens and 
operant responding for alcohol by rats (Blomqvist et al., 1993, Blomqvist et al., 1996, 
Kuzmin et al., 2009). Furthermore, varenicline, a partial agonist of α4β2 nAChRs, has 
also been shown to decrease alcohol seeking and intake in rats (Steensland et al., 2007) 
and reduce alcohol intake in heavy-drinking people who smoke (McKee et al., 2009). 
 
The Effect of Alcohol on the Hippocampus 
 Alcohol affects the structure and function of many regions of the brain, however 
one consequence of an AUD – and of particular importance to our studies – is 
hippocampal neurodegeneration. The hippocampus is a region of the brain known for its 
role in learning and memory. Several drugs of abuse have been shown to adversely 
affect hippocampal function, which may foster contextual conditioning that results in cue-
induced drug craving (Koob and Volkow, 2010). Furthermore, alcoholics often display 
neurocognitive deficits that include impairments attributed to the hippocampus (Parsons, 
1998). However, with abstinence, former alcoholics show significant improvements in 
hippocampus-dependent functions (Bartels et. al., 2007) and cognitive abilities (Fein et 
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al., 2006). For example, a meta-analysis showed that alcoholics demonstrate impaired 
spatial learning and memory during the first year of abstinence, but return to control 
levels during more prolonged abstinence (Stavro et al., 2013). Therefore, it is 
hypothesized that some mechanism of hippocampal recovery exists. 
 In addition to studies demonstrating the effect of alcohol on hippocampal 
function, other groups have found that alcohol also affects hippocampal structure. For 
example, one study measuring hippocampal volumes in humans found that chronic 
alcoholics had lower anterior hippocampal volume than social drinking controls (Sullivan 
et al., 1995). Several other groups have also shown hippocampal volume loss resulting 
from alcoholism (Agartz et al., 1999, Beresford et al., 2006, Mechtcheriakov et al., 2007); 
however, studies finding no effect of alcohol on hippocampal neuron loss exist as well 
(Harding et al., 1997). Additionally, adolescent drinkers appear to be particularly 
susceptible to alcohol-induced hippocampal damage (White and Swartzwelder, 2004). A 
study measuring hippocampal volume via magnetic resonance imaging found that 
people who developed AUDs during adolescence had lower hippocampal volumes than 
those who did not; furthermore, younger age at onset of AUD and longer duration were 
associated with lower hippocampal volumes (De Bellis et al., 2000).  
 Animal studies evaluating the neurodegenerative effects of alcohol on the 
hippocampus have also been performed. For example, an animal model has shown 
granule cell loss in the dentate gyrus and pyramidal cell loss in the CA regions following 
chronic ethanol consumption (Walker et al., 1980). Furthermore, rats that underwent 
four-day binge ethanol treatment had cell death in the DG as measured by silver staining 
and demonstrated impaired reversal learning in the Morris water maze (Obernier et al., 
2002). Another studying employing the four-day binge ethanol model found that female 
rats had fewer DG granule cells and increased hippocampal cell death as measured by 
FluoroJade B (Leasure and Nixon, 2010). Finally, NDMAR-dependent hippocampal 
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cytotoxicity has been demonstrated in organotypic hippocampal slices following chronic 
intermittent ethanol exposure and ethanol withdrawal (Reynolds et al., 2015). 
 
Adult Neurogenesis 
Adult neurogenesis, the process by which neural stem cells (NSCs) proliferate, 
differentiate into neurons, migrate into the granule cell layer, and survive and integrate 
into the neural network (Kempermann et al., 2004b), occurs in two brain regions: the 
subventricular zone (SVZ) of the lateral ventricle (Alvarez-Buylla and Garcia-Verdugo, 
2002) and the subgranular zone (SGZ) of the hippocampal dentate gyrus (DG) in 
animals and humans (Altman and Das, 1965, Eriksson et al., 1998). In rodents, neurons 
generated in the SVZ migrate along the rostral migratory stream to the olfactory bulb 
(Alvarez-Buylla and Garcia-Verdugo, 2002). However, the significance of adult 
neurogenesis in the SVZ of humans is unclear (Inta et al., 2015); therefore, only 
hippocampal adult neurogenesis will be discussed herein. Greater than 9,000 neurons – 
6% of the total population – are generated daily in the GCL of rats (Cameron and 
McKay, 2001). Hippocampal neurogenesis involves several steps: neural stem cells 
(NSCs) in the SGZ asymmetrically divide into amplifying progenitor cells, which 
differentiate into immature neurons and migrate into the GCL; if the cells survive to 
become mature neurons, they project dendrites into the molecular layer of the DG (von 
Bohlen und Halbach, 2011). NSCs, or Type 1 cells, have radial glial properties and are 
located in the SGZ; they express glial fibrillary acidic protein (GFAP), nestin (an 
intermediate filament), and SRY-related HMG-box gene2 – or Sox2 – a transcription 
factor (von Bohlen und Halbach, 2011). Type 2a and 2b cells are rapidly proliferating 
progenitors arising from Type 1 cells. Type 2b cells express doublecortin (DCX, a 
microtubule-associated protein that is a marker of immature neurons) and NeuroD (a 
transcripton factor), whereas Type 2a cells do not (Lee et al., 1995, Kempermann et al., 
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2004a). Type 3 cells are immature neurons that begin to migrate into the granule cell 
layer. Immature neurons eventually become postmitotic mature neurons that express 
neuron-specific nuclear protein (NeuN). Immunohistochemical staining procedures are 
also used to identify other markers expressed by cells in various stages of neurogenesis.  
Adult neurogenesis is hypothesized to be key to hippocampal function. 
Correlations provided the initial evidence that newborn neurons were related to DG 
structure and therefore function. For example, the number of granule cells in the 
hippocampal dentate gyrus doubled in rats that underwent hippocampus-dependent 
associative learning tasks (Gould et al., 1999). Furthermore, mice that had increased 
hippocampal neurogenesis via running or environmental enrichment showed enhanced 
learning (Nilsson et al., 1999, van Praag et al., 1999). Conversely, when neurogenesis 
was decreased, rats performed worse on hippocampus-dependent trace conditioning 
tasks (Shors et al., 2001). Causation was established by a study that showed that 
genetic ablation of newborn GCL neurons in mice resulted in contextual and spatial 
memory impairment (Imayoshi et al., 2008).  
Alcohol has been shown to have different effects on hippocampal adult 
neurogenesis during intoxication and abstinence. Four-day binge ethanol exposure in an 
animal model causes a decrease in neurogenesis immediately following the last dose of 
ethanol (Nixon and Crews, 2002). The study by Nixon and Crews in 2002 found that 
both hippocampal neural stem cell proliferation and survival were negatively impacted by 
binge ethanol in rats. Decreased neural stem cell proliferation following one, two, and 
four weeks of chronic ethanol administration has also been reported in rats (He et al., 
2005). Another study evaluating hippocampal neurogenesis in adult rats involving six 
weeks of alcohol administration showed decreased new cell survival contributing to 
impaired neurogenesis, but no effects on neural stem cell proliferation (Herrera et al., 
2003). However, during abstinence from four-day binge ethanol exposure, adult 
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hippocampal neurogenesis has been shown to increase as a result of increased neural 
stem cell proliferation (Nixon and Crews, 2004). This particular study is discussed in 
greater depth in the introduction of Chapter 1.  
Hippocampal adult neurogenesis has also been studied in adolescent animal 
models of AUDs. In rats, postnatal days (PND) 28-42 are generally recognized as the 
period of adolescence, while PND 63 and over is considered adulthood (Spear, 2000, 
Sengupta, 2013). The first study to show an effect of alcohol on hippocampal 
neurogenesis was conducted by Crews et al. in 2006. This study found that acute doses 
of ethanol administered intragastrically to male adolescent rats reduced BrdU and 
doublecortin immunoreactivity (Crews et al., 2006). Furthermore, our lab has shown that 
binge ethanol administration acutely decreases hippocampal neurogenesis through 
decreased neural stem cell proliferation and survival in adolescent rats (Morris et al., 
2010a) and induces hippocampal neurogenesis on the seventh day of abstinence 
(McClain et al., 2014). The same study found an increased number of ectopic 
neuroblasts in the molecular layer and hilus of the hippocampal dentate gyrus at this 
same time point during abstinence in rats that underwent severe withdrawal, indicating 
that adolescents may have impaired neuronal incorporation into hippocampal circuitry 
(McClain et al., 2014). An adolescent intermittent ethanol exposure model showed 
decreases in dorsal and ventral hippocampal neurogenesis that persisted into adulthood 
and was associated with diminished cognitive function in the novel object recognition 
task (Vetreno and Crews, 2015). Another model using a different ethanol administration 
pattern during adolescence also showed persistent decreases in hippocampal 
neurogenesis that were hypothesized to be the result of increased immature neuronal 
cell death (Broadwater et al., 2014). 
Nicotine has been shown to cause decreases in hippocampal adult neurogenesis 
in various animal models, which will be discussed in greater depth in Chapter 3. Briefly, 
11 
 
different doses and administration schedules have shown that nicotine decreases 
hippocampal neurogenesis when measured immediately following administration. Some 
studies have concluded that nicotine decreases neurogenesis by diminishing cell 
proliferation, while others have postulated that the decrease is a result of reduced cell 
survival. None of the studies have evaluated the effect of nicotine on neurogenesis 
during abstinence. Additionally, nicotine has been shown to induce hippocampal cell 
death in both adolescent and adult rats, which will also be thoroughly discussed in 
Chapter 3. However, this information is important to keep in mind when discussing the 
hypothesis.  
 
Hypothesis 
 Alcoholics demonstrate impaired cognitive function and diminished ability to 
perform hippocampal-dependent tasks (Parsons, 1998). Moreover, alcohol has been 
shown to induce hippocampal neurodegeneration in humans and animal models of 
AUDs. One of its mechanisms of neurodegeneration is via the reduction of adult 
neurogenesis occurring in the hippocampal DG – a process that is essential for proper 
hippocampal function (Imayoshi et al., 2008) – during intoxication (Nixon and Crews, 
2002). However, following four-day binge ethanol exposure, cell proliferation returns to 
normal by the third day of abstinence (Nixon and Crews, 2004, Nixon et al., 2008). On 
the seventh day of abstinence, it has been shown that a burst in cell proliferation occurs 
that results in increased neurogenesis in the DG (Nixon and Crews, 2004). In order to 
eventually reveal the mechanism by which this ethanol-induced reactive neurogenesis 
occurs, it is necessary to determine the timing of the initiation of cell proliferation. 
Therefore, the aim for Experiment 1 was to develop a timeline of cell proliferation in the 
SGZ of the hippocampal DG on days 4, 5, 6, and 7 of abstinence in order to determine 
on which day it begins. Then, Experiment 2 will build upon the results of Experiment 1 to 
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examine the effects of nicotine and alcohol co-administration on cell proliferation at the 
point of peak proliferation in adolescent rats.  
 Although nicotine is generally considered to have beneficial effects on cognition 
(Levin et al., 2006), it has been shown to have toxic effects on the hippocampus through 
multiple mechanisms. First, nicotine has been shown to induce hippocampal cell death 
in both adult and adolescent rats (Abrous et al., 2002, Jang et al., 2002, Abreu-Villaca et 
al., 2003, Demiralay et al., 2008). Additionally, nicotine has been shown to decrease 
adult hippocampal neurogenesis during exposure (Abrous et al., 2002, Jang et al., 2002, 
Shingo and Kito, 2005, Scerri et al., 2006, Wei et al., 2012). However, no studies have 
assessed nicotine’s effect on hippocampal neurogenesis during abstinence, nor have 
they measured the effect of nicotine co-administration on alcohol-induced reactive 
neurogenesis. As most alcoholics smoke (Miller and Gold, 1998, Falk et al., 2006, De 
Leon et al., 2007, Van Skike et al., 2016), and many people begin smoking and drinking 
during adolescence, it is critical to evaluate the effect of these drugs when administered 
in combination during adolescence. Based on the fact that nicotine induces hippocampal 
neurotoxicity and acutely decreases hippocampal neurogenesis during administration – 
similar to the neurotoxicity and decreased neurogenesis seen during alcohol 
administration – the hypothesis of Experiment 2 is that nicotine increases reactive 
hippocampal cell proliferation during abstinence and has an additive effect on reactive 
cell proliferation during abstinence when co-administered with alcohol. 
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Chapter Two: Timeline of Reactive Alcohol-Induced Hippocampal Cell 
Proliferation 
 
Introduction 
 Previous work has shown that there is a decrease in cell proliferation in the 
subgranular zone (SGZ) of the hippocampal dentate gyrus (DG) immediately after the 
last dose of ethanol is administered after four days of binge ethanol exposure in a 
modified Majchrowicz model as depicted in Figure 2.1 (Nixon and Crews, 2002, 2004). 
However, cell proliferation returns to control levels on the first day of abstinence (T24) as 
shown in Figure 2.2 (Nixon et al., 2008). Then, on the second day of abstinence (T48), 
an increase in the number of proliferating cells marked by BrdU occurs; however, these 
cells were shown to be microglia and did not reflect changes in neurogenesis. 
Furthermore, these BrdU+ cells were located not only in the SGZ, but also throughout 
the hilus and molecular layer of the DG, the CA regions of the hippocampus, and cortical 
regions – areas where neurogenesis does not occur. Interestingly, on the seventh day of 
abstinence there is a 350% increase in the number of proliferating cells marked by BrdU 
in ethanol exposed animals compared to controls that does reflect increases in 
neurogenesis. This work showed that the increased cell proliferation at day 7 of 
abstinence resulted in increased neurogenesis by measuring doublecortin (DCX) on day 
14 of abstinence. Doublecortin is a protein that is associated with microtubules and is 
expressed by migrating, newly differentiated neuroblasts within 4-7 days after cell birth 
(Gleeson et al., 1999, Brown et al., 2003). Furthermore, this study by Nixon and Crews 
showed that most of these cells survived 28 days after the burst in cell proliferation on 
day 7 of abstinence.  
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Figure 2.1: Timeline of cell proliferation 
 
Figure 2.1 Timeline of cell proliferation in the hippocampal dentate gyrus following four 
days of binge ethanol exposure in a modified Majchrowicz model. Cell proliferation was 
measured by BrdU incorporation into dividing cells. Cell proliferation on the second day 
of abstinence (T48) is reflective of microglia proliferation (Nixon et al., 2008), whereas 
cell proliferation on the seventh day of abstinence (T168 or T7) results in increased 
neurogenesis (Nixon and Crews, 2004). *p<0.05 versus control 
 
As previously discussed, neural stem cell proliferation is the first step in the 
process of adult neurogenesis. Therefore, the initial step in studying this phenomenon is 
to examine cell proliferation in the subgranular zone of the hippocampal dentate gyrus, a 
brain region where neurogenesis is known to occur. In order to better understand the 
timeline of reactive adult neurogenesis during abstinence from alcohol, Experiment 1 
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investigated the timeline of cell proliferation on days 4, 5, 6, and 7 to determine when the 
increase in adult neurogenesis begins.   
 
Methods 
Fifty-two adult male Sprague Dawley rats (~PND 70) with an initial weight of 
approximately 300 grams (Charles River Laboratories, Raleigh, NC) underwent four 
days of binge ethanol exposure as described below. There were a total of 32 rats in the 
ethanol treatment group and 20 rats in the control group (Table 2.1); however, not all of 
the BrdU injections successfully incorporated into the brain (cite Eisch et al., 2000 – in 
PNAS acknowledges this and has a method), so four ethanol rats from the T4 group, two 
ethanol rats from the T5 group, two ethanol rats from the T6 group, four ethanol rats 
from the T7 group, and nine control animals had to be excluded from analyses. At four, 
five, six, and seven days of abstinence following the last dose of alcohol (i.e. T4-T7), a 
group of ethanol and control animals were given BrdU and euthanized in the manner 
described below in order to develop a timeline of neural stem cell proliferation (Figure 
2.2). 
 
Table 2.1: Experiment 1 Design 
Euthanasia time point Ethanol Control 
T4 n=8 n=4 
T5 n=8 n=4 
T6 n=8 n=4 
T7 n=8 n=8 
Table 2.1 Original number of animals within each group. Twelve rats total were planned 
to be euthanized four, five, and six days after the last dose of ethanol (T4-T6) and 16 
rats were planned to be euthanized on day seven of abstinence (T7). 
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Figure 2.2: Experiment 1 Timeline 
 
Figure 2.2 An experimental timeline showing the timing of ethanol administration and 
euthanasia during abstinence. Sac = sacrifice/euthanasia. BrdU = bromodeoxyuridine.  
 
Animal Model of an Alcohol Use Disorder (AUD) 
A binge ethanol exposure model modified from Majchrowicz (1975) was used 
throughout all experiments as previously described (Morris et al., 2010b). This model 
produces blood ethanol concentrations (BECs) of roughly 325 mg/dL, approximately four 
times the legal limit, to mimic the high BECs found in alcoholics who drink in a binge-
bender pattern. The model has been shown in our lab and in others to cause 
neurodegeneration, decreased hippocampal neurogenesis during intoxication, and 
increased hippocampal neurogenesis during abstinence from alcohol (Collins et al., 
1996, Nixon and Crews, 2002, 2004, Kelso et al., 2011). Additionally, the rats develop 
tolerance to alcohol and undergo withdrawal during abstinence.  
 All animals were group-housed with two to three rats per cage on a 12 hour 
light:dark cycle with free access to water and chow except during binge treatment when 
chow was removed. All procedures were approved by the University of Kentucky 
Institutional Animal Care and Use Committee and were consistent with the Guide for the 
Care and Use of Laboratory Animals (National Research Council, 1996). The animals 
were handled for three consecutive days prior to the beginning of ethanol administration 
in order to minimize stress. The rats were administered either ethanol (25% w/v in 
Vanilla Ensure Plus®) or control diet via intragastric gavage three times per day (at 7am, 
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3pm, and 11pm) for four days. The ethanol and control diets were calorie-matched. Rats 
were given an initial ethanol dose of 5 g/kg, and subsequent doses (ranging between 0 
and 5 g/kg) were titrated according to their behavioral intoxication score (Table 2.2). This 
model maximizes BECs without affecting mortality (Majchrowicz, 1975). In order to 
ensure that there were no nutritional differences between ethanol and control groups, 
control animals were administered the average volume of diet received by ethanol 
animals. To prevent dehydration, any animal with an intoxication score of four or five 
was given two milliliters of water. 
 
Table 2.2: Behavioral Intoxication Scale 
Intoxication 
Score 
Behavior 
Dose of 
Ethanol 
0 Normal animal 5 g/kg 
1 Hypoactive, mildly ataxic 4 g/kg 
2 Ataxic, elevated animal 3 g/kg 
3 
Ataxic, loss of abdominal elevation, delayed righting 
reflex 
2 g/kg 
4 Loss of righting reflex, retained eye blink reflex 1 g/kg 
5 Loss of righting reflex, loss of eye blink reflex 0 g/kg 
Table 2.2 Scale used to evaluate each rat’s behavioral intoxication prior to ethanol 
administration and determine the dose of ethanol to give. 
 
BECs were measured by collecting tail blood on the third day of the binge (after 
the 7th dose), 90 minutes after ethanol administration, the point at which rats reach peak 
BEC after oral gavage (Kelly et al., 1987, Livy et al., 2003). Blood was collected into 
eppendorfs that contained five microliters of heparin. Following blood collection, all 
samples were centrifuged at 1800g for five minutes, resulting in the separation of 
erythrocytes from plasma. Centrifuged samples were stored at -20°C. To measure the 
BEC of each animal, five microliters of blood plasma was placed into an AM1 Alcohol 
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Analyser (Analox, London, UK) and run in triplicate. The machine was calibrated using a 
300 mg/dL standard. 
 Eight hours after the last dose of ethanol was administered, all animals were 
single-housed and given free access to standard rat chow. Ten hours after the last dose 
of ethanol was administered, monitoring of withdrawal behavior was initiated for all rats 
receiving ethanol. Monitoring occurred for 30 minutes of every hour for 18 consecutive 
hours and withdrawal was assessed according to a previously developed scale as 
shown in Table 2.3 (Penland et al., 2001, Morris et al., 2010b).  
 
Table 2.3: Withdrawal Behavior Scale 
Score Withdrawal Behavior 
1.0 Hyperactivity 
1.4 Tail tremor 
1.6 Tail spasm 
2.0 Caudal tremor 
2.2 Arched back, on tiptoes 
2.4 Splayed limbs 
2.6 General tremor 
3.0 Head tremor 
3.2 Induced running 
3.4 Wet dog shakes 
3.6 Chattering teeth 
3.8 Spontaneous convulsions 
4.0 Death 
Table 2.3 Scale used to measure withdrawal severity based on behavior. This scale is a 
modification of Penland et al., 2001 which essentially assigned a score to each behavior 
rather than categorizing severity as in Majchrowicz’s (1975) original paper. 
 
Two hours prior to euthanasia, all rats were administered a saturating dose of 5-
bromo-2’-deoxyuridine (BrdU, Roche Diagnostics, Mannheim, Germany; 300mg/kg) via 
intraperitoneal injection (Cameron and McKay, 2001). The 20mg/mL BrdU solution for 
injection was prepared by dissolving the BrdU crystals in 0.9% NaCl. Rats were 
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administered a lethal dose of pentobarbital sodium solution (Fatal-Plus®, Vortech 
Pharmaceuticals, Dearborn, MI) and underwent transcardial perfusion with 0.1M 
phosphate buffered saline (PBS, pH 7.5) followed by 4% paraformaldehyde. Rat brains 
were extracted shortly after euthanasia and placed into 4% paraformaldehyde for 24 
hours of post-fixation before being transferred to and stored in 0.1M PBS at 4˚C until 
sectioning. Brains were sliced into 40 micrometer coronal sections in a 1:12 series using 
a vibrating blade microtome (Leica Biosystems, Buffalo Grove, IL) and stored in 
cryoprotectant at -20°C.          
 
 
Bromodeoxyuridine (BrdU) Immunohistochemistry 
 Every sixth coronal brain section was processed for free-floating BrdU 
immunohistochemistry using published methods (Nixon and Crews, 2004). Tissue was 
washed in tris buffered saline (TBS) and endogenous peroxidases were quenched with 
0.6% hydrogen peroxide. Antigen retrieval through DNA denaturation was then 
performed by placing the tissue into 50% formamide/2x saline sodium citrate for 2 hours 
at 65°C and 2N HCl for 1 hour at 37°C followed by pH neutralizing washes in 0.1M boric 
acid. The tissue was next placed into blocking solution to prevent nonspecific antibody 
binding (3% horse serum and 0.1% triton X in TBS). An additonal DNA denaturing step 
was then done by putting the tissue into a deoxyribonuclease I solution (100U 
DNase/1mL of 0.02% MgCl2 in TBS) for 1 hour. The tissue was then incubated in a 
1:4400 dilution (subjects from the T4 and T5 euthanasia time points) or 1:5000 dilution 
(subjects from the T6 and T7 euthanasia time points) of mouse anti-BrdU (Millipore 
MAB3424, Temecula, CA) overnight at 4°C. The next day, the tissue was rinsed in 
blocking solution and incubated in biotinylated horse anti-mouse, rat adsorbed 
secondary antibody (Vector Laboratories, Burlingame, CA) for 1 hour at 37°C. Following 
20 
 
this step, the tissue was placed into an avidin-biotinylated horseradish peroxidase 
complex solution (ABC Elite Kit; Vector Laboratories), which binds the biotin and 
amplifies the signal of the secondary antibody (Volpicelli-Daley and Levey, 2004). 
Finally, nickel-enhanced 3,3’-diaminobenzidine tetrahydrochloride (DAB; Polysciences, 
Warrington, PA), a chromagen that undergoes an enzymatic reaction with the 
horseradish peroxidase in ABC, was used to allow the BrdU+ cells to be visualized 
(black color). Following immunohistochemical staining, all tissue sections were mounted 
onto glass slides, dried, lightly counterstained with cresyl violet, and coverslipped with 
Cytoseal® (Stephens Scientific, Wayne, NJ).     
All cells labeled with BrdU (BrdU+) in the subgranular zone of the hippocampal 
dorsal dentate gyrus (Bregma -2.64 to -5.28) were quantified via profile counting on an 
Olympus BX-41 light microscope at 1000x with an oil immersion lens (UPlanSApo 100x; 
numerical aperture 1.4, Olympus). During quantification, the experimenter was blinded to 
the treatment condition. Previous work has shown that the profile counting method 
results in percent change identical those produced by stereological methods of cell 
quantification and may be more appropriate for the non-homogenously distributed BrdU 
profiles (Crews et al., 2004, Noori and Fornal, 2011). 
 
Statistical Analyses 
Data were analyzed and graphed using Prism Version 6.05 (GraphPad Software, 
Inc. La Jolla, CA). Data are reported as mean ± standard error of the mean. Results 
were considered statistically significant if p<0.05. All animals that failed to incorporate 
BrdU into the brain were excluded from all analyses. Nonparametric, animal model 
subject data including intoxication scores and mean and peak withdrawal scores were 
analyzed with the Kruskal-Wallis test. Parametric, BECs and daily ethanol dose data 
were analyzed by one-way ANOVA. BrdU cell counts in rats receiving ethanol and 
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euthanized at all 4 time points were compared to a common control group, collapsed 
across time points via a one-way ANOVA with Dunnet’s post hoc test. Correlations of 
parametric data, i.e. between BrdU+ cell counts and blood ethanol concentration or daily 
ethanol dose were analyzed by Pearson correlation; all other correlations of subject data 
with BrdU cell counts utilized the nonparametric Spearman correlation. 
 
Results 
Animal Model Subject Data 
The mean weight of the rats on the first day of binge ethanol exposure was 329 ± 
2.7 grams. Because diet restriction has been shown to promote adult neurogenesis, 
initial body weight and the change in body weight during the four day binge period were 
measured to identify potential differences between groups (Lee et al., 2002). One-way 
ANOVA showed no differences in initial body weights or percentage of body weight lost 
between any of the groups (Table 2.4).   
 
Table 2.4: Experiment 1 Animal Weight Data 
Group Initial body weight 
(grams) 
Change in body weight 
(%) 
Control (n=11) 327 ± 6 -11.5 ± 0.3 
T4 (n=4) 322 ± 5 -13.7 ± 1.3 
T5 (n=6) 332 ± 6 -11.9 ± 1 
T6 (n=6) 338 ± 4 -13.9 ± 0.7 
T7 (n=4) 326 ± 8 -11.2 ± 2.9 
Table 2.4 Initial body weight and change in body weight following 4 days of binge 
ethanol exposure were both statistically similar between groups.  
 
One-way ANOVA of blood ethanol concentrations (grand mean = 358 ± 18.4 
mg/dL) and daily dose of ethanol administered (grand mean = 9.9 ± 0.3 g/kg/day) 
revealed no significant differences between the four groups. The mean BEC and daily 
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ethanol dose are in accordance with the values routinely produced by this model (Nixon 
and Crews, 2004, Morris et al., 2010b, Kelso et al., 2011). Furthermore, Kruskal-Wallis 
tests of intoxication score, mean withdrawal score, and peak withdrawal score showed 
no significant differences between groups (Table 2.5).  
 
Table 2.5: Experiment 1 Animal Model Subject Data 
Group Intoxication 
Score     
 (0-5 scale) 
Dose 
(g/kg/day) 
BEC 
(mg/dL) 
Mean 
Withdrawal 
(0-4 scale) 
Peak 
Withdrawal 
(0-4 scale) 
T4 1.8 ± 0.1 9.7 ± 0.3 324 ± 5 0.64 ± 0.1 3.4 ± 0.2 
T5 1.6 ± 0.1 10.1 ± 0.4 330 ± 44 0.86 ± 0.2 3.1 ± 0.1 
T6 1.9 ± 0.1 9.2 ± 0.3 412 ± 11 0.72 ± 0.2 3.4 ± 0.2 
T7 1.5 ± 0.4 10.6 ± 1.1 356 ± 42 0.79 ± 0.1 3.5 ± 0.2 
Table 2.5 No statistical differences between groups were detected in any of the 
behavioral parameters or BECs associated with the modified Majchrowicz model. 
 
Time Course of Cell Proliferation 
In order to investigate the timing of reactive cell proliferation during the period of 
abstinence following binge ethanol exposure, the number of BrdU+ cells in the 
subgranular zone of the hippocampal dentate gyrus were quantified 4, 5, 6, and 7 days 
post binge ethanol administration (T4-T7; Figure 2.3). A one-way ANOVA showed no 
difference in BrdU+ cell counts between control groups at all four time points. Therefore, 
all controls were collapsed into one group (n=11). A one-way ANOVA showed a 
significant effect of group on the number of BrdU+ cells (F4,26=29.69; p<0.0001). 
Dunnett’s post hoc test comparing each time point to control showed that there was no 
difference in the number of BrdU+ cells in the ethanol group versus the control group at 
four days of abstinence (T4; n=4); however, there was a 70% increase in the number of 
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BrdU+ cells at T5 (p<0.05; n=6), a 121% increase at T6 (p<0.05; n=6), and a 233% 
increase at T7 (p<0.05; n=4). 
 
 
Figure 2.3: Time Course of Cell Proliferation in the Hippocampal Dentate Gyrus  
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Figure 2.3: The number of BrdU+ cells in the subgranular zone (SGZ) of the 
hippocampal dentate gyrus (DG), a measure of cell proliferation, increased beginning 5 
days into abstinence (T5), graphed in panel A. Panel B shows representative images of 
BrdU+ cells in the DG for each group. BrdU+ cells located in the granule cell layer (GCL) 
or hilus were not quantified. * p<0.05 compared to the control group. Scale bar = 100µm, 
20µm inset. 
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Correlations were conducted to probe for a relationship between any of the 
subject data collected during binge ethanol exposure – including level of behavioral 
intoxication, BEC, and withdrawal severity – and the number of BrdU+ cells in the SGZ 
at T7, which appears to be the point of peak cell proliferation during abstinence (Table 
2.6; Figure 2.4). Spearman nonparametric correlation of intoxication score, mean 
withdrawal, and peak withdrawal scores were not significantly correlated with BrdU+ cell 
count. Furthermore, Pearson correlation analysis showed that BEC and daily ethanol 
dose were not correlated with the number of BrdU+ cells. 
 
Table 2.6: Correlations of Animal Model Subject Data with BrdU Cell Counts at T7 
 
 
 
 
Table 2.6 Correlations were used to examine whether any relationships exist between 
the measured animal model parameters and BrdU cell counts at day 7 of abstinence 
(T7). None of the animal model parameters showed a statistically significant correlation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Animal model parameter Correlation coefficient  
(P value)  
Mean withdrawal  0.40  (0.75) 
Peak withdrawal -0.32  (0.50 
Intoxication score -0.20  (0.92) 
Dose  0.23  (0.77) 
BEC  0.02  (0.98) 
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Figure 2.4: Correlations of Animal Model Subject Data with BrdU Cell Counts at T7 
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Figure 2.4. None of the animal model parameters showed a statistically significant 
correlation with BrdU cell count at T7.  
 
Discussion 
  This experiment builds on the work of Nixon and Crews (2004) to determine the 
start of the reactive cell proliferation that has been shown to occur in rats during 
abstinence following four days of binge ethanol exposure. The results of this study show 
A 
B DC 
B
E 
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that cell proliferation in the subgranular zone of the hippocampal dentate gyrus is 
increased in ethanol-exposed animals beginning on day 5 of abstinence (T5) and 
continues to increase on days 6 and 7. Furthermore, the T7 time point data replicated 
previous work though the fold change over control appears to be less. The BrdU 
analysis reported by Nixon and Crews (2004) included BrdU+ cells in both the granule 
cell layer and the subgranular zone. In this experiment, only BrdU+ cells in the SGZ 
were quantified, which may better predict increases in neurogenesis as this is the region 
where neural stem cells proliferate.   
Studies evaluating reactive neurogenesis in response to insults other than 
alcohol have shown a similar timeline of cell proliferation. For example, one study of rats 
found that focal cerebral ischemia induced reactive cell proliferation in the SGZ one 
week after the insult; furthermore, cell proliferation returned to control levels two weeks 
after ischemia occurred (Jin et al., 2001). Another study examining focal ischemia in 
gerbils showed that cell proliferation increased beginning 6 days after the insult, peaked 
at day 11, and returned to control levels 3 weeks after the event (Liu et al., 1998). A 
model involving pilocarpine-induced status epilepticus in rats, which is notable because 
the Majchrowicz model produces withdrawal seizures in some rats, demonstrated 
increased cell proliferation in the SGZ 3, 6, and 13 days after seizure and resulted in 
increased neurogenesis (Parent et al., 1997). Thus, events inducing cell death including 
ischemia and seizures have been shown to result in compensatory neurogenesis along 
a somewhat similar timeline as alcohol. These data add to our understanding of the time 
course of cell proliferation events after an acutely damaging exposure to alcohol: cell 
proliferation increases gradually over days of abstinence until reaching a peak, at which 
point it returns to normal levels.  
 It is important to note that although it can be concluded that cell proliferation 
increases on day 5 of abstinence, it cannot be definitively concluded that adult 
27 
 
neurogenesis increases on day 5 of abstinence. BrdU labels all proliferating cells in the 
S phase of the cell cycle; thus, BrdU can label proliferating glial cells or neural stem cells 
that will eventually differentiate into glia. As previously discussed, increases in cell 
proliferation on day 2 of abstinence reflect microglial proliferation rather than NSC 
proliferation (Nixon et al., 2008). However, based on prior work showing that cell 
proliferation in this brain region on day 7 of abstinence (T7) results in increased 
neurogenesis, it can be inferred that increased cell proliferation on day 5 of abstinence 
also results in increased adult neurogenesis. In order to conclude that increased cell 
proliferation at T5 does in fact result in increased neurogenesis, future studies could 
involve quantifying doublecortin or NeuroD (markers of immature neurons) on day 12 of 
abstinence, which is one week after cell proliferation increases and by which time the 
cell fate of the proliferating NSCs would have been determined (Seki, 2002, Brown et al., 
2003). Moreover, rats could be injected with BrdU on day 5 of abstinence and 
euthanized 28 days later (T35) in order to determine whether the proliferating cells 
survive, as cell survival is a crucial step in process of adult neurogenesis. Lastly, at T35, 
by which time the proliferating NSCs would have become mature neurons, fluorescent 
immunohistochemistry could be used to determine whether there is co-localization of 
BrdU and NeuN (a marker of mature neurons). Co-localization would indicate that the 
proliferating cells labeled with BrdU at T5 differentiated and survived to become mature 
neurons. Another issue to consider is that BrdU is exogenously administered and its 
bioavailability could influence the interpretation of these data. To obtain more conclusive 
results regarding cell proliferation, future work should involve quantifying the number of 
Ki-67+ cells in this same brain region on day 5 of abstinence.  Ki-67 is an endogenous 
marker of cell proliferation that labels proliferating cells in all phases of the cell cycle 
except for the resting phase (Scholzen and Gerdes, 2000). Ki-67+ cells are increased in 
parallel to BrdU+ cells in all studies to date (Nixon and Crews, 2004, Nixon et al., 2008).  
28 
 
 As discussed above, seizures have been shown to induce reactive hippocampal 
neurogenesis (Parent et al., 1997); therefore, it is necessary to rule out withdrawal 
seizure as the cause of alcohol-induced reactive neurogenesis. Although prior studies 
using the binge ethanol model have demonstrated that BrdU+ cell number positively 
correlates with withdrawal severity, a study using 10mg/kg diazepam to decrease 
withdrawal severity showed that animals exhibiting very few behavioral signs of 
withdrawal still had increased cell proliferation at T7 (Nixon and Crews, 2004). Moreover, 
although CNS hyperexcitability via glutamate transmission occurs during alcohol 
withdrawal (Rossetti and Carboni, 1995, Dahchour and De Witte, 1999), agonism of 
NMDA receptors by glutamate has actually been shown to result in decreased 
hippocampal neurogenesis via reduced cell proliferation (Cameron et al., 1995). 
Therefore, it is not thought that withdrawal contributes much to reactive adult 
neurogenesis during abstinence. Furthermore, in this experiment, none of the animal 
model subject data including BEC, daily ethanol dose, intoxication score, mean 
withdrawal score, or peak withdrawal score correlated with the number of BrdU+ cells in 
the SGZ. However, it is possible that the lack of any significant correlations is due to the 
small number of animals in the T7 ethanol group.   
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Chapter Three: Effect of Nicotine and Alcohol Co-administration on Reactive Cell 
Proliferation 
 
Introduction 
 Nicotine has been shown to cause decreases in hippocampal adult neurogenesis 
in various animal models. One study found that when high doses of nicotine were 
intravenously self-administered daily for 42 days, hippocampal neurogenesis was 
decreased when measured during the last three days of self-administration (Abrous et 
al., 2002). Moreover, the decrease in neurogenesis was accompanied by an increase in 
cell death in the granule cell layer as measured by pyknotic cells. The authors 
hypothesize that these cells were a mix of mature neurons, newborn cells, and NSCs 
based on their location throughout the GCL but could not conclusively determine what 
cell phenotypes were dying. Another study showed that nicotine administered 
subcutaneously at a dose of 4 mg/kg/day through an osmotic mini pump for ten days – a 
dose that produces blood nicotine levels similar to that of heavy smoking and that results 
in desensitization of nAChRs – decreased cell proliferation in the DG and caused an 
impairment in spatial memory as measured by the Morris water maze (Scerri et al., 
2006). A study conducted in male adolescent rats (PND 30) showed that three days of 
once daily 1 mg/kg intraperitoneal doses of nicotine decreased cell proliferation in the 
SGZ when measured by BrdU administration during all three days of nicotine exposure 
(Jang et al., 2002). Moreover, similarly to the study by Abrous et al., this study found 
increased cell death in the DG as measured by the number of TUNEL+ cells, pyknotic 
cells, and caspase-3 positive cells. Not only does nicotine impair cell proliferation, it has 
also been shown to reduce cell survival following three weeks of intravenous nicotine 
self-administration at a mean dose of 0.2 to 0.25 mg/kg (Wei et al., 2012). Finally, it has 
been shown that 0.1 mg/kg, 0.5 mg/kg, and 1 mg/kg daily intraperitoneal doses of 
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nicotine for 14 days causes decreased numbers of PSA-NCAM+ cells and NeuN+ cells 
in the DG of PND 28 rats (Shingo and Kito, 2005). PSA-NCAM – the polysialylated 
embryonic form of the neural cell adhesion molecule – is considered a marker of 
neurogenesis as it has been shown to be expressed in newborn granule cells (Seki and 
Arai, 1991, Seki, 2002, von Bohlen und Halbach, 2011). In summary, most of the studies 
evaluating nicotine’s effect on neurogenesis have concluded that nicotine decreases 
hippocampal neurogenesis. 
 The mechanism by which nicotine effects adult hippocampal neurogenesis is 
unknown, but thought to be related to its effects on the cholinergic system (Nixon et al., 
2011). The cholinergic system is well known to be associated with cognitive function 
and, as previously discussed, hippocampal neurogenesis is also thought to be 
necessary for hippocampal functions such as learning and memory (Eichenbaum, 2004, 
Imayoshi et al., 2008). Multiple approaches have been taken to determine the influence 
of the cholinergic system on adult neurogenesis. In one study, an immunotoxin was 
infused into the lateral ventricle of rats in order to lesion cholinergic neurons located in 
the cholinergic basal forebrain that send projections to the hippocampal DG (Cooper-
Kuhn et al., 2004). Lesioning of these neurons resulted in decreased neurogenesis in 
the GCL and increased apoptotic cells in the SGZ; therefore, the authors of this study 
hypothesized that cholinergic input promotes cell survival. Moreover, when rats were 
treated with donepezil, an acetylcholinesterase inhibitor (AChEI) that increases levels of 
acetylcholine (ACh), neurogenesis in the DG was increased through increased cell 
survival (Kotani et al., 2006). Therefore, it can be hypothesized that nicotine acts to 
decrease hippocampal neurogenesis through its desensitization of nAChRs and the 
resulting decreases in cholinergic activity (Nixon et al., 2011).   
Based on the finding from Experiment 1 that cell proliferation in the SGZ of the 
hippocampal DG peaks on day 7 of abstinence from alcohol (T7) and the knowledge that 
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most people start consuming alcohol and smoking tobacco during adolescence, the goal 
of Experiment 2 was to examine the effect that nicotine co-administration has on cell 
proliferation at this time point during abstinence from both alcohol and nicotine. As 
previously discussed, reactive neurogenesis has been shown to occur following events 
that induce cell death, including alcohol, ischemia, and seizure. Nicotine has also been 
shown to induce cell death in some animal models. The studies by Abrous et al. in 2002 
and Jang et al. in 2002 that were just discussed showed that nicotine induced cell death 
in the DG at the same doses that affected neurogenesis. Furthermore, another study 
showed increased TUNEL-positive cells – a measure of apoptotic cell death – in the 
hippocampus of adult rats administered 0.6 mg/kg nicotine intraperitoneally daily for 21 
days (Demiralay et al., 2008). A study conducted in adolescent rats that compared the 
effect of nicotine dose and route of administration on neurotoxicity showed that 0.3mg/kg 
doses of nicotine administered subcutaneously twice daily for one week beginning at 
PND 30 – a model similar to ours – showed neurotoxic effects in the hippocampus 
(Abreu-Villaca et al., 2003). The authors of this study evaluated neurotoxicity by 
assessing cell packing density, cell size, cell number, and neurite projections via 
fluorescent dye-binding and modified dot-immunobinding techniques. Finally, 
preliminary, unpublished data from our lab shows that our model of nicotine 
administration in adolescent rats potentiates ethanol-induced cell death in the entorhinal 
cortex, a brain region that projects to the hippocampus as measured by FluoroJade B. 
Although these studies demonstrate nicotine toxicity, many other studies support 
nicotine’s role in neuroprotection. As neurogenesis has been shown to be acutely 
decreased by both alcohol and nicotine during use and reactively increased during 
abstinence from alcohol, we hypothesized that nicotine increases reactive hippocampal 
neurogenesis during abstinence and has an additive effect on reactive neurogenesis 
during abstinence when co-administered with alcohol.    
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Methods 
In this experiment, a total of 46 adolescent male Sprague-Dawley rats (Charles 
River Laboratories, Raleigh, NC) were used. Rats were group-housed and handled 
identically to rats in experiment 1 as described in Chapter 2. PND 29 rats were treated 
with ten days of either nicotine or saline with the modified Majchrowicz binge ethanol 
treatment overlapping with the last four days of nicotine treatment (see Figure 3.1). 
Binge ethanol administration and tail blood collection for BEC analysis were conducted 
as described in detail in Chapter 2, except for chow availability (discussed below). There 
were five treatment groups: ethanol diet plus nicotine injection (Ethanol/Nicotine), 
ethanol diet plus saline injection (Ethanol/Saline), control diet plus nicotine injection 
(Control/Nicotine), control diet plus saline injection (Control/Saline), and an ad libitum 
group (Table 3.1). Rats in the ad libitum group did not receive diet or injections; they had 
free access to water and standard rat chow throughout the whole experiment and were 
handled only while being weighed. All animals received BrdU injections (300mg/kg; i.p.) 
and were sacrificed on day seven of abstinence (T7) as described in Chapter 2. Two 
cohorts of animals were run for this experiment; Cohort 2 underwent the treatment 
model approximately nine months after Cohort 1. The experiment was run in two cohorts 
due to its size with the intention of combining them for analyses.  
 
Figure 3.1: Experiment 2 Timeline 
Figure 3.1 An experimental timeline showing the timing of ethanol and nicotine 
administration, BrdU labeling of cell proliferation and euthanasia during abstinence.  
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 A sterile 0.3 mg/mL nicotine solution (pH=7.4) was prepared fresh, daily from (-)-
nicotine liquid (Sigma-Aldrich, Saint Louis, Missouri) and 0.9% NaCl. Nicotine was 
injected subcutaneously as a 0.3 mg/kg dose and was given three times a day on the 
same schedule as ethanol administration beginning on postnatal day 29. An equal 
volume of 0.9% NaCl (normal saline; 1 mL/kg) was administered subcutaneously in 
control groups. 
In Cohort 1, one rat from the ethanol/nicotine group died during the period of 
withdrawal monitoring; however, the death was most likely a delayed result of gavage 
error or severe ethanol intoxication as the animal did not show any behavioral signs of 
withdrawal. One rat from the control/nicotine group died during the four day binge period 
from gavage error. 
Cohort 2 underwent the same nicotine/ethanol treatment paradigm as Cohort 1; 
however, Cohort 2 received rat chow during the four days of ethanol administration while 
Cohort 1 had no access to food during this period. A problem with excessive weight loss 
in adolescent rats during the 4 day binge period was noticed between the time that 
Cohort 1 and Cohort 2 were run. Therefore, Cohort 2 was given rat chow during the 
binge in order to combat the weight loss. On the first and second days of ethanol 
exposure, 10 grams of rat chow were placed into the bottom of the cage every day at the 
3pm time point so that every rat in all groups (except the ad libitum group) received 
approximately 5 grams of food per day. All of the rat chow was eaten on both days, so 
on the third day of ethanol exposure 16 grams of rat chow was placed into the cage. All 
of the rat chow was again eaten, so on the fourth and final day of ethanol exposure, 20 
grams of rat chow was placed into the cage. Additionally, 8 hours after the last dose of 
diet and injections were administered, all rats (except those in the ad libitum group), 
were given 20 mL/kg of control diet to prevent additional weight loss during the 
withdrawal period. No rats from Cohort 2 died. 
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Table 3.1: Experiment 2 – Experimental Design 
Group 
Ethanol/
Nicotine 
Ethanol/
Saline 
Control/
Nicotine 
Control/
Saline 
Ad 
libitum 
Cohort 1 n=5 n=5 n=5 n=5 n=4 
Cohort 2 n=5 n=5 n=4 n=4 n=4 
Table 3.1 Original number of animals within each group in both cohorts.  
 
BrdU immunohistochemistry was performed in the manner described in Chapter 
2. The same primary antibody was used at a concentration of 1:4400. The only 
procedural difference in this experiment is that tissue sections were not counterstained 
with cresyl violet as DAB staining was dark enough to allow the GCL and other brain 
regions to be easily defined. 
 
Statistical Analyses 
Data were analyzed and graphed using Prism Version 6.05 (GraphPad Software, 
Inc. La Jolla, CA). Data are reported as mean ± standard error of the mean. Results 
were considered statistically significant if p<0.05. The Mann-Whitney U test was used to 
compare intoxication scores and mean and peak withdrawal scores between the 
ethanol/nicotine and ethanol/saline groups within each cohort; Mann-Whitney U tests 
were used in this experiment because only two groups were being compared, while 
Kruskal-Wallis tests were used in Experiment 1 because four groups were being 
compared. A student’s t-test was used to compare BECs and daily ethanol doses 
between these groups. BrdU+ cell counts were analyzed by two-way ANOVA followed 
by a Tukey’s post hoc test. BEC and daily ethanol dose correlations with BrdU+ cell 
counts were analyzed by Pearson correlation; all other correlations of subject data with 
BrdU+ cell counts were analyzed by Spearman nonparametric correlation. 
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Results 
Animal Model Subject Data 
Nicotine has been shown to cause weight loss through both decreased food 
intake and increased energy expenditure (Audrain-McGovern and Benowitz, 2011, 
Mineur et al., 2011). Furthermore, as previously discussed, caloric restriction can effect 
adult neurogenesis. Therefore, an analysis of initial body weight and the change in body 
weight over the course of the ten days of nicotine administration (and ethanol 
administration during the last four days of nicotine exposure) was conducted for both 
Cohorts 1 and 2 (excluding ad libitum animals; Table 3.2). Initial body weights of animals 
in the ad libitum group in Cohort 1 were not collected; therefore, no weight data from the 
ad libitum group is reflected in Table 3.2 and no statistical analyses could be conducted. 
 
Table 3.2: Experiment 2 Animal Weight Data 
Group Initial body weight (grams) Change in body weight (%) 
Cohort 1 72.6 ± 1.8 37.4 ± 1.9 
Cohort 2 83.6 ± 1.9 50.6 ± 2.5 
 
In order to evaluate the appropriateness of combining Cohorts 1 and 2 for the 
BrdU cell count analysis, subject data from the animal model was analyzed to verify that 
the model was performed similarly between the two cohorts. Mann-Whitney U 
nonparametric tests showed that Cohort 2 had a significantly lower mean intoxication 
score (p=0.0003), mean withdrawal score (p=0.0002), and peak withdrawal score 
(p=0.0014) than Cohort 1. A t-test also showed that Cohort 2 received a significantly 
greater daily dose of ethanol (t14=5.546; p<0.0001); however, the cohorts had a 
statistically similar BEC (Table 3.3). The mean BECs of both cohorts are lower than 
expected; moreover, the intoxication and withdrawal scores of Cohort 2 are lower than 
expected and the daily dose of ethanol administered is higher than previously reported 
(Morris et al., 2010a, McClain et al., 2011, McClain et al., 2014). 
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Table 3.3: Animal Model Subject Data – Cohort 1 vs. Cohort 2 
Group 
 
Intoxication 
Score         
(0-5 scale)* 
Dose* 
(g/kg/day) 
BEC 
(mg/dL) 
Mean 
Withdrawal 
(0-4 scale)* 
Peak 
Withdrawal 
(0-4 scale)* 
Cohort 1 
(n=7) 
0.96 ± 0.1 12.1 ± 0.4 281 ± 34 1.7 ± 0.2 3.3 ± 0.2 
Cohort 2 
(n=9) 
0.27 ± 0.05 14.3 ± 0.1 257 ± 31 0.12 ± 0.03 1.4 ± 0.3 
Table 3.3 Cohort 2 had significantly lower intoxication scores, mean withdrawal scores, 
and peak withdrawal scores than Cohort 1. Cohort 2 also received a significantly higher 
daily dose of ethanol than Cohort 1; however, the cohorts did not differ in BEC. *p<0.05. 
 
 Although differences existed between the two cohorts, the primary parameter 
that is critical to whether ethanol has an effect – BEC – was statistically similar between 
groups. Therefore, cohorts were combined as the study was designed.  When the 
ethanol/nicotine groups and the ethanol/saline groups from both cohorts were combined, 
there were no statistically significant differences between the ethanol/nicotine and 
ethanol/saline groups in any of the animal model parameters evaluated (Table 3.4).  The 
overall animal model subject parameters are similar – although slightly lower with the 
exception of daily ethanol dose – to those previously reported (Morris et al., 2010a, 
Morris et al., 2010b, McClain et al., 2011, McClain et al., 2014). 
  
Table 3.4: Animal Model Subject Data – Nicotine vs. Saline 
Treatment 
 
Intoxication 
Score        
(0-5 scale)
Dose 
(g/kg/day)
BEC 
(mg/dL) 
Mean 
Withdrawal 
(0-4 scale) 
Peak 
Withdrawal 
(0-4 scale)
Nicotine 
(n=9) 
0.53 ± 0.1 13.4 ± 0.4 297 ± 24 1 ± 0.3 2.2 ± 0.4 
Saline 
(n=7) 
0.61 ± 0.2 13.2 ± 0.5 230 ± 38 0.6 ± 0.2 2.3 ± 0.2 
Table 3.4 When Cohorts 1 and 2 were combined, all measured animal model 
parameters were statistically similar between nicotine and saline groups. 
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Ethanol increases BrdU incorporation at T7 
As discussed in Chapter 2, BrdU labels all proliferating cells in the S phase of the 
cell cycle; however, in order to more specifically identify proliferating NSCs, only BrdU+ 
cells in the SGZ were quantified. Control animals show a basal level of BrdU+ cells in 
the SGZ. A second analysis to determine whether it was appropriate to combine the two 
cohorts compared the number of BrdU+ cells in the various control groups between the 
two cohorts. A two-way ANOVA did not reveal any significant differences in BrdU+ cell 
counts in the control/saline group versus the ad libitum control group or between each 
cohort. Therefore, since the original intention of the experiment was to combine the two 
cohorts as long as there were no differences in BEC or control BrdU+ cell counts, and to 
combine the control/saline groups with the ad libitum controls, all controls were 
combined. All BrdU counts were then analyzed by two-way ANOVA which showed a 
significant main effect of ethanol on BrdU+ cell count (F1,35=31.42; p<0.0001), but no 
effect of nicotine (Figure 3.2). Moreover, there was no interaction between ethanol and 
nicotine. Tukey’s post hoc test showed that the ethanol/nicotine and ethanol/saline 
groups both had a greater number of BrdU+ cells in the SGZ than the control/nicotine 
and control/saline groups (p<0.05).  
 
Figure 3.2: BrdU+ Cells in the SGZ of the Hippocampal DG at T7 
  
A 
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Figure 3.2 Rats receiving ethanol showed greater numbers of BrdU+ cells in the 
subgranular zone of the hippocampal dentate gyrus at day 7 of abstinence than rats 
receiving control diet. Nicotine had no effect on BrdU+ cell counts in either the ethanol or 
control group, graphed in Panel A.*p<0.05 compared to each ethanol group’s respective 
control group. Panel B shows representative images from each group in Cohort 1. Scale 
bar = 100µm, 40µm inset. 
Next, correlations were conducted to probe whether any of the factors involved in 
the adolescent nicotine/binge ethanol model, including level of behavioral intoxication, 
BEC, and withdrawal severity, were associated with the number of BrdU+ cells in the 
SGZ at T7 (Table 3.5; Figure 3.3). Spearman nonparametric correlation of intoxication 
score, mean withdrawal, and peak withdrawal revealed positive correlations of mean 
withdrawal score and intoxication score with BrdU+ cell count (Table 3.5). Pearson 
correlation analysis showed that neither daily ethanol dose nor BEC correlated with the 
number of BrdU+ cells. 
 
 
 
 
B 
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Table 3.5: Animal Model Subject Data Correlations with BrdU Cell Counts at T7 
Animal model parameter Correlation coefficient (p value) 
Mean withdrawal* 0.58 (0.02) 
Peak withdrawal 0.36 (0.17) 
Intoxication score* 0.68 (0.005) 
Dose -0.35 (0.35) 
BEC 0.49 (0.055) 
Table 3.5 Correlations suggest a relationship between mean withdrawal score and mean 
intoxication score with the number of BrdU+ cells. *p<0.05. 
Figure 3.3: Correlations of Animal Model Subject Data with BrdU Cell Counts at T7 
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Figure 3.3 BrdU+ cell number positively correlates with mean withdrawal score and 
intoxication score. None of the other animal model parameters showed a statistically 
significant correlation with BrdU+ cell count.  
 
Discussion 
 This study examined for the first time, the effect of nicotine on alcohol-induced 
reactive cell proliferation in a model of alcohol dependence.  These data replicated the 
reactive cell proliferation that occurs after 4-day binge ethanol exposure (Nixon and 
Crews, 2004), however, nicotine exposure prior to and during the four-day binge had no 
effect on alcohol-induced reactive cell proliferation at T7 of abstinence. Even though 
previous studies reported an effect of nicotine on cell proliferation (Abrous et al., 2002, 
Jang et al., 2002, Scerri et al., 2006), a variety of factors may explain the lack of effect of 
nicotine on hippocampal cell proliferation in this study. First, this study was conducted 
following seven days of abstinence from nicotine, whereas all the other studies 
evaluated cell proliferation and neurogenesis immediately following the period of nicotine 
administration. From these results, it is possible to infer that acute nicotine-induced 
decreases in hippocampal neurogenesis do not persist to the seventh day of abstinence. 
Furthermore, nicotine-induced reactive cell proliferation during abstinence resulting from 
neurotoxicity to the developing adolescent brain may not occur on T7, the day at which it 
was evaluated in this study. In order to determine whether the timeline of nicotine-
induced cell proliferation is different than that of ethanol-induced cell proliferation – or 
whether it occurs at all – an experimental design similar to that of Experiment 1 
evaluating nicotine rather than ethanol could be performed. Second, the dose of nicotine 
chosen may not have been one that influences neurogenesis. In the seminal study 
where nicotine decreased neurogenesis, only the two highest doses of intravenous 
nicotine (0.04 mg/kg and 0.08 mg/kg) had an effect (Abrous et al., 2002). Moreover, the 
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study by Scerri et al. in 2006 showed that ten days of continuous nicotine exposure 
delivered subcutaneously by an osmotic mini pump at a dose of 4 mg/kg/day  –  but not 
0.25 mg/kg/day – decreased cell proliferation in the DG. The authors of this study 
postulated that the lower dose of nicotine, which reflects the blood nicotine levels of light 
smokers, had no effect on neurogenesis because the low dose did not desensitize 
nAChRs, whereas the higher dose did. It is unknown whether the dose and 
administration schedule of nicotine in this study desensitized nAChRs. In order to 
evaluate whether our chosen dose and administration schedule acutely influences 
neurogenesis in the manner described by the other studies, animals could be injected 
with BrdU on the last day of nicotine administration and euthanized. This experimental 
design would make it possible to determine whether acute decreases in cell proliferation 
occur in the DG following ten days of thrice daily 0.3 mg/kg subcutaneous nicotine 
injections. However, preliminary, unpublished data from our lab shows that doublecortin, 
a marker of immature neurons, is decreased by nicotine immediately following our 
nicotine/ethanol administration model. Therefore, preliminary data with DCX shows that 
our nicotine administration model potentially acutely reduces neurogenesis during 
exposure. Furthermore, a different model of nicotine exposure may produce changes in 
neurogenesis not seen with our model. For example, although other models of nicotine 
exposure have resulted in decreased hippocampal neurogenesis, a model of extended 
access nicotine exposure with periodic deprivation produced an increase in immature 
hippocampal neurons (Cohen et al., 2015). In this model, adult male rats were provided 
with 0.03 mg/kg doses of nicotine to intravenously self-administer 21 hours per day for 
four days and then denied nicotine access for three days. The cycle was repeated for a 
total of 14 weeks. This model of nicotine administration was chosen by the authors 
because it has been shown to produce an increased motivation for nicotine self 
administration following deprivation as a result of nicotine dependence and withdrawal.  
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Therefore, it is possible to hypothesize that models of nicotine administration that induce 
nicotine dependence differentially affect hippocampal neurogenesis. Finally, our model 
of nicotine administration may not affect cell proliferation, but rather cell survival, which 
would result in effects on adult neurogenesis that could not be measured through our 
BrdU experiment that was designed to assay effects on cell proliferation. To evaluate 
this possibility, animals could be injected with BrdU at some point during abstinence and 
then euthanized four weeks later. BrdU cell counts could then be used to determine 
whether more proliferating cells survived for four weeks in animals receiving nicotine. 
 Importantly, animals in the ad libitum group showed the same level of basal cell 
proliferation at the time of euthanasia as animals receiving control diet via intragastric 
gavage and subcutaneous saline injections. This demonstrates that neither weight loss 
nor stress from injections and/or gavage have a long-term effect on cell proliferation in 
this region of the brain. This information is important as glucocorticoids, which are 
increased by stress, have been shown to reduce hippocampal neurogenesis in adult rats 
(Cameron and Gould, 1994). 
 Correlations revealed that mean withdrawal score and intoxication score were 
positively correlated with the number of BrdU+ cells in the SGZ. This indicates that the 
more intoxicated the rats behave, the greater the number of BrdU+ cells in the SGZ. 
Furthermore, as shown in Figure 3.3, the greater the withdrawal severity, the greater the 
number of BrdU+ cells. This correlation was not unexpected as prior studies using the 
binge ethanol model have demonstrated that BrdU+ cell number positively correlates 
with withdrawal severity in both adults and adolescents (Nixon and Crews, 2004, 
McClain et al., 2014). As discussed in Chapter 2, although seizures have been shown to 
induce reactive hippocampal neurogenesis (Parent et al., 1997), this group ruled out the 
role of alcohol-withdrawal seizures in reactive neurogenesis by using 10 mg/kg 
diazepam to decrease withdrawal severity. Again, they showed that adult rats exhibiting 
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very few behavioral signs of withdrawal still had increased cell proliferation at T7 (Nixon 
and Crews, 2004). Even though this study with diazepam was conducted in adult rats, it 
is expected to apply to adolescent rats as well based on the results of a study 
qualitatively and quantitatively comparing withdrawal from binge ethanol exposure in 
adult and adolescent rats that found no differences (Morris et al., 2010b).  
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Chapter Four: Overall Conclusions 
Alcohol has been shown to be toxic to the hippocampus, a region of the brain 
involved in learning and memory. As evidence of this, alcoholics – or those with AUDs – 
demonstrate structural damage to the hippocampus and volume loss (Sullivan et al., 
1995, Agartz et al., 1999, Beresford et al., 2006, Mechtcheriakov et al., 2007). 
Furthermore, alcohol has been shown in many animal models to induce cell death in the 
hippocampus and areas of the brain that project to the hippocampus (Walker et al., 
1980, Obernier et al., 2002, Leasure and Nixon, 2010, Kelso et al., 2011). Although 
nicotine is generally considered to be neuroprotective, some groups have shown a toxic 
effect of nicotine on the hippocampus (Abreu-Villaca et al., 2003, Abrous et al., 2002, 
Demiralay et al., 2008, Jang et al., 2002). Additionally, several studies have evaluated 
the effects of co-abuse of nicotine and alcohol on neurodegeneration in humans through 
magnetic resonance imaging. Smoking worsened alcohol-induced gray matter loss in 
both heavy drinking alcoholics and alcoholics undergoing treatment who had been 
abstinent for one week (Gazdzinski et al., 2008). Moreover, both alcohol and nicotine 
have been shown to be particularly toxic in adolescents (Abreu-Villaca et al., 2003, 
White and Swartzwelder, 2004). Although alcohol may induce neurodegeneration 
through a variety of mechanisms (Crews and Nixon, 2009), our group is particularly 
interested in the contributions of adult hippocampal neurogenesis.   
The impact of alcohol and nicotine on hippocampal function has not only been 
shown in animal models, but also in humans. The effect of nicotine on cognitive function 
has historically been thought to be beneficial (Levin et al., 2006). However, a study of 
the effect of nicotine on cognitive performance in adolescent smokers showed that 
adolescent smokers performed worse on tests of verbal memory than nonsmokers 
following 24 hours of abstinence, but performed the same as nonsmokers during periods 
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when they were allowed free access to cigarettes (Jacobsen et al., 2005). Furthermore, 
the effects of nicotine and alcohol co-administration on cognitive performance in humans 
have been studied. For example, one study that sampled people with AUDs involved in a 
clinical trial testing different behavioral therapies to treat their addiction found that 
chronic alcohol abuse was associated with reduced scores on neurocognitive tests. 
Furthermore, alcoholics who smoked performed even worse on these tests, indicating 
that nicotine has an additive effect on alcohol-induced cognitive impairments. However, 
the effect size of alcohol on cognitive impairment was very small – in fact, most 
alcoholics scored within normal limits – which conflicts with other studies that found 
significant reductions in performance on cognitive tests in alcoholics (Friend et al., 
2005). Taken together, these studies and others indicate that nicotine and alcohol do in 
fact impact cognitive function in humans and that studies in animal models 
demonstrating cognitive impairment may be applicable to humans. 
Mechanisms of hippocampal recovery have been suggested to exist. In one 
particular study, 60% of the alcoholics included initially demonstrated dysfunction in a 
battery of hippocampus-dependent tests that assessed verbal and nonverbal learning 
and visuospatial memory (Bartels et al., 2007). Following two years of abstinence, 
performance on these tasks was significantly improved and actually returned to normal. 
These data from Bartels et al. indicate that some mechanism of hippocampal recovery 
during abstinence must exist. The improvement in hippocampal functioning that 
abstinent alcoholics demonstrate could be related to reactive neurogenesis (Nixon and 
Crews, 2004), and as such it is very important to study this phenomenon in order to 
potentially develop therapies that target this process to aid cognitive recovery during 
abstinence. Adult neurogenesis – the process by which new neurons are born –  in the 
hippocampus has been shown to be an important factor in hippocampal function (Gould 
et al., 1999, Nilsson et al., 1999, Shors et al., 2001, Imayoshi et al., 2008). Moreover, as 
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discussed herein, adult neurogenesis has been shown to be modulated by alcohol and 
nicotine. Both alcohol and nicotine have been shown to suppress hippocampal 
neurogenesis during use in adult and adolescent animal models (Abrous et al., 2002, 
Broadwater et al., 2014, Crews et al., 2006, Jang et al., 2002, Morris et al., 2010, Nixon 
and Crews, 2002, Scerri et al., 2006, Vetreno and Crews, 2015). However, neurogenesis 
has been shown to reactively increase during abstinence from alcohol (Nixon and 
Crews, 2004). No studies have examined the effect of nicotine on hippocampal 
neurogenesis during abstinence, nor have they evaluated the effect of nicotine co-
administration on alcohol-induced reactive neurogenesis. Therefore, the goal of the 
experiments herein was to determine whether nicotine potentiates alcohol-induced 
reactive hippocampal cell proliferation on the day at which peak cell proliferation occurs 
during abstinence from alcohol. 
In conclusion, this study showed that reactive cell proliferation increases on day 
5 of abstinence and continues to increase through day 7 of abstinence. This discovery 
made it possible to examine the effect of nicotine on peak cell proliferation during 
abstinence from alcohol. Moreover, it is now possible to examine hippocampal brain 
slices at the time when reactive neurogenesis begins in order to determine the cellular 
mechanisms and signaling pathways responsible for reactive neurogenesis. Future work 
will aim to clarify that the increased cell proliferation at T5 does in fact result in increased 
neurogenesis. Furthermore, although the same time course of cell proliferation is 
hypothesized to occur in adolescent rats, future work could involve replicating this 
experiment in adolescent animals. Our study looking at the effect of nicotine on reactive 
adult hippocampal neurogenesis in adolescent rats at the point of peak cell proliferation 
showed that neither nicotine alone nor in combination with alcohol had an effect on cell 
proliferation. This result was not expected as we had anticipated that nicotine would 
potentiate alcohol-induced cell proliferation. Although the result was not expected, as 
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previously discussed, several possible explanations exist and it cannot be conclusively 
ruled that nicotine has no effect on hippocampal neurogenesis. Future work should 
involve demonstrating that our model of nicotine administration results in decreased cell 
proliferation during use or experimenting with different models of nicotine administration. 
Furthermore, coming studies could examine whether nicotine influences cell survival 
rather than cell proliferation during abstinence.  
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